Literature DB >> 17003413

Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis.

Alicja R Rudnicka1, Shahrul Mt-Isa, Christopher G Owen, Derek G Cook, Deborah Ashby.   

Abstract

PURPOSE: To quantify the variation in primary open-angle glaucoma (OAG) prevalence with age, gender, race, year of publication, and survey methodology.
METHODS: Medline, EMBASE, and PubMed were searched for studies of OAG prevalence. Studies with defined population samplings were sought. Forty-six published observational studies of OAG prevalence (103,567 participants with 2509 cases of OAG) were identified for inclusion in the systematic review and meta-analysis. Data on the number of people and the number of cases of OAG by age, race, and gender were sought for each study. Additional information was obtained regarding whether the definition of glaucoma relied on raised intraocular pressure (IOP) and whether visual field examination was performed routinely on all individuals. Bayesian meta-analysis was used to model the associations between the log odds of OAG and age, race, gender, year of publication, method of visual field testing, and effect of reliance on IOP in the definition of OAG.
RESULTS: Black populations had the highest OAG prevalence at all ages, but the proportional increase in prevalence of OAG with age was highest in white populations. The odds ratio per decade increase in age was 2.05 in white populations (95% credible interval, 1.91 to 2.18), 1.61 (95% credible interval, 1.53 to 1.70) in black populations, and 1.57 (95% credible interval, 1.46 to 1.68) in Asian populations. The average estimated prevalence in those older than 70 years of age was 6% in white populations, 16% in black populations, and 3% in Asian populations. After adjusting for age, race, year of publication, and survey methods, men were 1.37 (95% credible interval, 1.22 to 1.53) times more likely than women to have OAG. The prevalence of OAG was one third lower in studies in which routine visual fields were not assessed and that used an IOP criterion in the definition of glaucoma; this effect was reduced to the null after adjustment for age, racial group, and year of publication.
CONCLUSIONS: Although black populations had the highest prevalence of OAG at all ages, white populations showed the steepest increase in OAG prevalence with age. Men were more likely than women to have OAG.

Entities:  

Mesh:

Year:  2006        PMID: 17003413     DOI: 10.1167/iovs.06-0299

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  139 in total

1.  Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.

Authors:  Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt
Journal:  Arch Ophthalmol       Date:  2012-10

2.  Biomarkers for glaucoma: from the lab to the clinic.

Authors:  N Von Thun Und Hohenstein-Blaul; S Kunst; N Pfeiffer; F H Grus
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

3.  Genome-wide association and admixture analysis of glaucoma in the Women's Health Initiative.

Authors:  Thomas J Hoffmann; Hua Tang; Timothy A Thornton; Bette Caan; Mary Haan; Amy E Millen; Fridtjof Thomas; Neil Risch
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

4.  24-hour IOP telemetry in the nonhuman primate: implant system performance and initial characterization of IOP at multiple timescales.

Authors:  J Crawford Downs; Claude F Burgoyne; William P Seigfreid; Juan F Reynaud; Nicholas G Strouthidis; Verney Sallee
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-21       Impact factor: 4.799

5.  The prevalence of developmental dysplasia of the hip in idiopathic clubfoot: a systematic review and meta-analysis.

Authors:  Talal Ibrahim; Muhammad Riaz; Abdelsalam Hegazy
Journal:  Int Orthop       Date:  2015-04-07       Impact factor: 3.075

6.  Racial disparities in the use of ancillary testing to evaluate individuals with open-angle glaucoma.

Authors:  Joshua D Stein; Nidhi Talwar; Alejandra M Laverne; Bin Nan; Paul R Lichter
Journal:  Arch Ophthalmol       Date:  2012-12

7.  Prevalence of glaucoma in an urban West African population: the Tema Eye Survey.

Authors:  Donald L Budenz; Keith Barton; Julia Whiteside-de Vos; Joyce Schiffman; Jagadeesh Bandi; Winifred Nolan; Leon Herndon; Hanna Kim; Graham Hay-Smith; James M Tielsch
Journal:  JAMA Ophthalmol       Date:  2013-05       Impact factor: 7.389

Review 8.  Gender and glaucoma: what we know and what we need to know.

Authors:  Thasarat S Vajaranant; Sushma Nayak; Jacob T Wilensky; Charlotte E Joslin
Journal:  Curr Opin Ophthalmol       Date:  2010-03       Impact factor: 3.761

9.  Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension.

Authors:  Nicholas P Bell; José L Ramos; Robert M Feldman
Journal:  Clin Ophthalmol       Date:  2010-11-22

10.  RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma.

Authors:  Mao Li; Jianjiang Xu; Xueli Chen; Xinghuai Sun
Journal:  Diagn Pathol       Date:  2009-12-16       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.